Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha Schaefer Solle

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine DosesMeghan K Herring, James K Romine, Meredith G Wesley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
JMIR Research Protocols|October 18, 2021
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort StudyLaura J Edwards, Ashley L Fowlkes, Meredith G Wesley, et al.
Nature Communications|September 27, 2024
Towards geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
Emerging Infectious Diseases|January 26, 2023
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline WorkersKatherine D Ellingson, James Hollister, Cynthia J Porter, et al.
MMWR. Morbidity and Mortality Weekly Report|April 1, 2021
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021Mark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
JAMA|October 18, 2022
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers, Mark G Thompson, Sarang K Yoon, et al.
Influenza and Other Respiratory Viruses|January 13, 2022
Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021Allison L Naleway, Lauren Grant, Alberto J Caban-Martinez, et al.
MMWR. Morbidity and Mortality Weekly Report|March 17, 2022
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022Ashley L Fowlkes, Sarang K Yoon, Karen Lutrick, et al.
The New England Journal of Medicine|June 30, 2021
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 VaccinesMark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine DosesMeghan K Herring, James K Romine, Meredith G Wesley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
JMIR Research Protocols|October 18, 2021
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort StudyLaura J Edwards, Ashley L Fowlkes, Meredith G Wesley, et al.
Nature Communications|September 27, 2024
Towards geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
Emerging Infectious Diseases|January 26, 2023
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline WorkersKatherine D Ellingson, James Hollister, Cynthia J Porter, et al.
MMWR. Morbidity and Mortality Weekly Report|April 1, 2021
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021Mark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
JAMA|October 18, 2022
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers, Mark G Thompson, Sarang K Yoon, et al.
Influenza and Other Respiratory Viruses|January 13, 2022
Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021Allison L Naleway, Lauren Grant, Alberto J Caban-Martinez, et al.
MMWR. Morbidity and Mortality Weekly Report|March 17, 2022
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022Ashley L Fowlkes, Sarang K Yoon, Karen Lutrick, et al.
The New England Journal of Medicine|June 30, 2021
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 VaccinesMark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
Pageof 9